Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 82.30M | $ 84.85M | $ 85.56M | $ 140.55M | $ 368.93M |
Total Assets | $ 2.24B | $ 2.29B | $ 2.12B | $ 2.16B | $ 2.78B |
Total Debt | $ 255.57M | $ 332.49M | $ 269.12M | $ 258.15M | $ 472.67M |
Net Debt | $ 173.27M | $ 247.64M | $ 183.56M | $ 117.60M | $ 103.74M |
Total Liabilities | - | $ 902.43M | $ 779.07M | $ 783.67M | $ 976.60M |
Stockholders Equity | $ 1.46B | $ 1.38B | $ 1.34B | $ 1.37B | $ 1.80B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |